Pivotal bioVenture Partners Fund I U.G.P. Ltd

CIK 1752847 · last filed 2025-11-12

Pivotal bioVenture Partners Fund I U.G.P. Ltd is a corporate insider who has filed 4 SEC Form 4 insider transactions across 1 company since 2020. Across all open-market trades the lifetime net is +$32.8M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

4

Lifetime Open-Market Net

$32.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Inozyme Pharma, Inc. (INZY) Delisted Director 1,571,741 $4.00 $6.29M $32.84M 3 2023-08-03

Recent Filings

4 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-11-12 Conv (C) +10,103,925 $0
2023-08-03 Inozyme Pharma, Inc. (INZY) Delisted Buy (P) +2,499,999 $12.00M EDGAR
2022-04-20 Inozyme Pharma, Inc. (INZY) Delisted Buy (P) +3,210,000 $11.84M EDGAR
2020-07-28 Inozyme Pharma, Inc. (INZY) Delisted Mixed +4,773,462 $9.00M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.